In Odisha, Shop Supplying Duplicate Medicines To Chhattisgarh Raided

BALANGIR: A joint team of Titlagarh and Chhattisgarh police raided a medicine shop in Bolangir district late last night for allegedly selling duplicate medicines.

The crackdown from the police came following the allegations that the medicine shop named Ayesha Medical Store was supplying duplicate medicine to neighbouring Chhattisgarh.

The raid was carried out in presence of the magistrate, sources informed, adding that, the police have informed the Directorate of Drug Control, Odisha about the incident.

It is worthwhile to mention here that the sale of duplicate medicine in the market is nothing new in Odisha.

In 2023, spurious blood pressure medicines ‘Telma 40’ and Telma AM were seized in Cuttack. Subsequently, two accused allegedly involved in supplying spurious hypertension medicines to distributors in Cuttack were arrested from Bihar.

Moreover, duplicate Clavam 625 capsules were also seized in Bhubaneswar and Jharsuguda in 2023.

Besides, Purighat police had recovered fake drugs worth Rs 2 lakh from a pharmaceutical distributor in Cuttack in 2023.

Related Posts

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Bengaluru: The Central Council for Research in Ayurvedic Sciences (CCRAS) has called for stronger scientific evidence, safety monitoring and translation of research into market-ready technologies to improve the credibility and…

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Ayurveda needs stronger evidence, safety monitoring for market adoption, says CCRAS

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform